C07C 229/70
The carbon skeleton being further substituted by singly-bound oxygen atoms
Official title: the carbon skeleton being further substituted by singly-bound oxygen atoms
C07C229/70 (The carbon skeleton being further substituted by singly-bound oxygen atoms) appears on 4 US grants and 4 published applications in this corpus.
Search patents in C07C- Granted patents
- 4
- Published applications
- 4
- Assignees
- 6
- Inventors
- 13
- Latest grant
- 12 Jan 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Cu-mediated annulation for the production of 1-amino-2-naphthalenecarboxylic acid derivatives12 Jan 2016US 9,233,911 B2Council of Scientific and Industrial Research
- Therapeutic molecules and methods-14 May 2010US 7,709,514 B2Cortical Pty Ltd
- Compounds18 Nov 1997US 5,688,945 AAstra Aktiebolag
- 3-hydroxy anthanilic acid derivatives26 Aug 1997US 5,661,183 AAstra Aktiebolag
- Cu-Mediated Annulation for the Production of 1-Amino-2-Naphthalenecarboxylic Acid Derivatives8 Jan 2015US 2015/0011781 A1Council of Scientific and Industrial Research
- Therapeutic Molecules and Methods-123 Dec 2010US 2010/0323999 A1
- Therapeutic molecules and methods-113 Jul 2006US 2006/0154977 A1Cortical Pty Ltd
- Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif)18 May 2006US 2006/0106102 A1
Most cited
By later US patents